🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesType 1.5 diabetes (LADA) and GLP-1 — what worked for you? Page 3

Type 1.5 diabetes (LADA) and GLP-1 — what worked for you?

pete_manc_UK Sun, Mar 16, 2025 at 5:43 AM 36 replies 2,172 viewsPage 3 of 8
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Mar 17, 2025 at 4:01 AM#11
hyun_seoul said:
PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

22 20wei_SG, cory_ATX, lori_vegas and 19 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Mar 17, 2025 at 5:39 PM#12
hank_denver said:
Glycemic variability as the key metric for glycaemic control success: my coefficient of variation (CV) on CGM dropped from 37% to 21%.

This is exactly what I could not find anywhere else. Taking it to my next appointment.

23 21Dr.ReproEndo, lucas_SP_BR, lisa_labSD and 20 others
Reply Quote Save Share Report
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Mar 18, 2025 at 7:17 AM#13
hyun_seoul said:
PCOS success story with glycaemic control: as someone with polycystic ovary syndrome, this medication has been transformative beyond weight loss.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

24 22patPC_UT, Dr.DermMIA, fiona_VT and 21 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Mar 18, 2025 at 8:56 PM#14

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

25 23Dr.PulmRoch, maya_sedona, stefan_berlin and 22 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Mar 19, 2025 at 10:35 AM#15

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

26 24PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 23 others
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register